Medicine has always been a promising area for investment, with an ongoing development of advanced technologies opening up even more opportunities. The healthcare services market, which for a long time existed mainly due to the public funding, is just beginning to actively attract private capital. The healthcare services market is scarcely subject to cyclical fluctuations, with demand for medical care and medicines remaining stable even against the background of macroeconomic turbulence, which creates very attractive conditions for investors. The reliability of investment in Xanodyne Pharmaceuticals is determined by the liquidity of products, thanks to the established supply chains in all 50 states, as well as already formed partnerships with the top-ranked healthcare companies and facilities. Another positive aspect of investing in medical technologies is the government assistance, which means certain tax benefits and advantages. Each country is concerned with maintaining the health of its population and therefore promotes supporting the investments in this area. Financial assisstance for the Xanodyne Pharmaceuticals operation helps achieve a desired outcome as quickly as possible and gives a chance to promote these technologies and implement them at once.